MAO inhibition and antidepressant activity.
D000328:Adult; D000928:Antidepressive Agents / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy; D002986:Clinical Trials as Topic; D003863:Depression / Q000188:drug therapy*; D006801:Humans; D007520:Isocarboxazid / Q000627:therapeutic use*; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use*; D009497:Neurotic Disorders / Q000188:drug therapy; D009526:Nialamide / Q000627:therapeutic use*; D010624:Phenelzine / Q000627:therapeutic use*; D010919:Placebos; D012559:Schizophrenia / Q000188:drug therapy
D000928:Antidepressive Agents; D008996:Monoamine Oxidase Inhibitors; D010919:Placebos; D007520:Isocarboxazid; D010624:Phenelzine; D009526:Nialamide